Zofran® was approved by the U.S. Food and Drug Administration (FDA) in 1991 to treat nausea and vomiting caused by chemotherapy and radiation. The drug was also prescribed to treat morning sickness in pregnant women, but it was not approved by the FDA for this use.
The Center for Birth Defects Research and Prevention published a study in 2012 suggesting that women who used Zofran® during the first trimester of pregnancy had a twofold increase risk of having a child with birth defects.
Possible Zofran birth defects may include cleft lip, cleft palate, and congenital heart defects. Although Zofran® was not approved by the FDA for morning sickness, GlaxoSmithKline (GSK) promoted off-label use of the drug. GSK agreed to pay $3 billion in 2012 to settle numerous allegations including illegally marketing Zofran® for non-approved use. Mothers who took Zofran® during pregnancy and had a child with cleft lip, cleft palate, or heart defects may be entitled to compensation. Contact a Zofran lawyer to find out if you and your child are eligible for compensation.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
5 Comments
joel santiago
my fiancee has been taking zofran through out her pregnancy-she's 5 months pregnant- because she's been suffering from severe morning sickness , should she stop taking zofran now? she takes the med 3 times a day.
angel
My daughter was taking zofran up to 4 months pregnant and is now 7 months pregnant. She took a few last week because naseua came back. Is there a way to know if it affected the baby?
Marlyn
My son was born with clubfeet and I took Zofran during the first few months of my pregnancy. Did Zofran cause my child to be born with this birth defect?
Christine
I took zofran during pregnancy my son died at 7 weeks old of heart issues
Brandi Marble
I took Zofran once, and then heard about this...is that little use something that could affect my baby?!?!
Comments for this article are closed.